Breakthrough Sars-Cov-2 Infections After Vaccination: A Critical Review

Breakthrough Sars-Cov-2 Infections After Vaccination: A Critical Review Publisher Pubmed

Mohseni Afshar Z¹ ; Barary M^{2, 3} ; Hosseinzadeh R⁴ ; Alijanpour A⁵ ; Hosseinzadeh D⁶ ; Ebrahimpour S⁷ ; Nazary K⁴ ; Sio TT⁸ ; Sullman MJM^{9, 10} ; Carsonchahhoud K¹¹ ; Babazadeh A⁷

Show Affiliations

1. Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran
2. Student Research Committee, Virtual School of Medical Education and Management, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3. Studentsâ€™ Scientific Research Center (SSRC), Tehran University of Medical Sciences, Tehran, Iran
4. Student Research Committee, Babol University of Medical Sciences, Babol, Iran
5. Faculty of Medicine, Semmelweis University, Budapest, Hungary
6. O. O. Bogomolets National Medical University, Kyiv, Ukraine
7. Infectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
8. Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ, United States
9. Department of Social Sciences, University of Nicosia, Nicosia, Cyprus
10. Department of Life and Health Sciences, University of Nicosia, Nicosia, Cyprus
11. Australian Centre for Precision Health, University of South Australia, Adelaide, Australia

Source: Human Vaccines and Immunotherapeutics Published:2022

Abstract

At the beginning of the current pandemic, it was believed that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection would induce lifelong immunity and that reinfections would be unlikely. However, after several cases of reinfection were documented in previously infected patients, this was understood to be a false assumption, and this waning humoral immunity has raised significant concerns. Accordingly, long-term and durable vaccine-induced antibody protection against infection have also become a challenge, as several breakthroughs of COVID-19 infection have been identified in individuals who were fully vaccinated. This review discusses the current evidence on breakthrough COVID-19 infections occurring after vaccination. © 2022 The Author(s). Published with license by Taylor & Francis Group, LLC.

Related Docs

View other Related Docs

1. Covid-19 Vaccinations: The Unknowns, Challenges, and Hopes, Journal of Medical Virology (2022)

2. The Effectiveness of Covid-19 Vaccines in Reducing the Incidence, Hospitalization, and Mortality From Covid-19: A Systematic Review and Meta-Analysis, Frontiers in Public Health (2022)

3. Immunogenicity of Covid-19 Mrna Vaccines in Immunocompromised Patients: A Systematic Review and Meta-Analysis, European Journal of Medical Research (2022)

4. Effectiveness of Covid-19 Vaccines Against Delta (B.1.617.2) Variant: A Systematic Review and Meta-Analysis of Clinical Studies, Vaccines (2022)

5. Short-Term Sars-Cov-2 Re-Infection Rate in Vaccinated Health Workers Based on Received Vaccines: A Cross-Sectional Study, Current Respiratory Medicine Reviews (2023)

6. Sars-Cov-2 Mrna-Vaccine Candidate; Corenapcin®, Induces Robust Humoral and Cellular Immunity in Mice and Non-Human Primates, npj Vaccines (2022)

7. The Chimera of S1 and N Proteins of Sars-Cov-2: Can It Be a Potential Vaccine Candidate for Covid-19?, Expert Review of Vaccines (2022)

8. Seroconversion Following the First, Second, and Third Dose of Sars-Cov-2 Vaccines in Immunocompromised Population: A Systematic Review and Meta-Analysis, Virology Journal (2022)

Experts (# of related papers)

View all Related Experts

Nima Rezaei (9)

Seyed Rohollah Miri (2)

Style	Citing Format
MLA	Mohseni Afshar Z, et al.. "Breakthrough Sars-Cov-2 Infections After Vaccination: A Critical Review." Human Vaccines and Immunotherapeutics, vol. 18, no. 5, 2022, pp. -.
APA	Mohseni Afshar Z, Barary M, Hosseinzadeh R, Alijanpour A, Hosseinzadeh D, Ebrahimpour S, Nazary K, Sio TT, Sullman MJM, Carsonchahhoud K, Babazadeh A (2022). Breakthrough Sars-Cov-2 Infections After Vaccination: A Critical Review. Human Vaccines and Immunotherapeutics, 18(5), -.
Chicago	Mohseni Afshar Z, Barary M, Hosseinzadeh R, Alijanpour A, Hosseinzadeh D, Ebrahimpour S, Nazary K, et al.. "Breakthrough Sars-Cov-2 Infections After Vaccination: A Critical Review." Human Vaccines and Immunotherapeutics 18, no. 5 (2022): -.
Harvard	Mohseni Afshar Z et al. (2022) 'Breakthrough Sars-Cov-2 Infections After Vaccination: A Critical Review', Human Vaccines and Immunotherapeutics, 18(5), pp. -.
Vancouver	Mohseni Afshar Z, Barary M, Hosseinzadeh R, Alijanpour A, Hosseinzadeh D, Ebrahimpour S, et al.. Breakthrough Sars-Cov-2 Infections After Vaccination: A Critical Review. Human Vaccines and Immunotherapeutics. 2022;18(5):-.
BibTex	@article{ author = {Mohseni Afshar Z and Barary M and Hosseinzadeh R and Alijanpour A and Hosseinzadeh D and Ebrahimpour S and Nazary K and Sio TT and Sullman MJM and Carsonchahhoud K and Babazadeh A}, title = {Breakthrough Sars-Cov-2 Infections After Vaccination: A Critical Review}, journal = {Human Vaccines and Immunotherapeutics}, volume = {18}, number = {5}, pages = {-}, year = {2022} }
RIS	TY - JOUR AU - Mohseni Afshar Z AU - Barary M AU - Hosseinzadeh R AU - Alijanpour A AU - Hosseinzadeh D AU - Ebrahimpour S AU - Nazary K AU - Sio TT AU - Sullman MJM AU - Carsonchahhoud K AU - Babazadeh A TI - Breakthrough Sars-Cov-2 Infections After Vaccination: A Critical Review JO - Human Vaccines and Immunotherapeutics VL - 18 IS - 5 SP - EP - PY - 2022 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract